Methylphenidate-Induced Sleep Bruxism Unresponsive to Adjunctive Guanfacine Rapidly Treated with Once Daily Buspirone in an 8 years old Girl

被引:0
|
作者
Ozdemir, Dilara [1 ]
Tufan, Ali Evren [1 ]
Yilmaz, Sumeyra [1 ]
Ozturk, Yusuf [2 ]
Sarioglu, Setenay [1 ]
机构
[1] Bolu Abant Izzet Baysal Univ, Med Fac, Bolu, Turkiye
[2] Ankara Etlik City Hosp, Ankara, Turkiye
来源
PSYCHIATRY AND BEHAVIORAL SCIENCES | 2024年 / 14卷 / 04期
关键词
Bruxism; Attention Deficit Hyperactivity Disorder; Side effect; Buspirone; Methylphenidate; ORAL-HEALTH; DOPAMINE; CHILDREN; BEHAVIOR;
D O I
10.5455/PBS.202.40825080923
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Attention deficit hyperactivity disorder (ADHD) is characterized by impairing inattention, hyperactivity, and impulsivity. Stimulants, including methylphenidate (MPH) are commonly used for its management. MPH has been previously associated with both sleep bruxism (SB) and awake bruxism (AB) in high doses. Here we report emergence of SB at a low dose of sustained release MPH which was unresponsive to guanfacine but rapidly responded to buspirone (BUS).
引用
收藏
页码:165 / 168
页数:4
相关论文
共 1 条